| P50 | author | Gary D Monheit | Q114092343 |
| P2093 | author name string | Andy Pickett | |
| P2860 | cites work | Properties and use of botulinum toxin and other microbial neurotoxins in medicine | Q23833526 |
| | Botulinum toxin injection of eye muscles to correct strabismus | Q24534234 |
| | Botulinum Neurotoxin Type A in Neurology: Update | Q26781047 |
| | Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A. | Q31142424 |
| | Treatment of strabismus in adults with botulinum toxin A. | Q33644462 |
| | Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the "sausage poison". | Q33880508 |
| | Pharmacologic weakening of extraocular muscles. | Q34204174 |
| | Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery | Q34282549 |
| | Botulinum toxin type A products are not interchangeable: a review of the evidence | Q34352934 |
| | Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis | Q34536279 |
| | Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin | Q34615234 |
| | A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines | Q35824499 |
| | Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins | Q35831352 |
| | The story of Clostridium botulinum: from food poisoning to Botox. | Q35831503 |
| | What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group | Q36317593 |
| | A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia | Q36317676 |
| | Clinical uses of botulinum neurotoxins: current indications, limitations and future developments | Q36395728 |
| | The protein load of therapeutic botulinum toxins | Q36771893 |
| | From poison to remedy: the chequered history of botulinum toxin | Q36801432 |
| | Use of intradermal botulinum toxin to reduce sebum production and facial pore size | Q37359536 |
| | Learning from the past: historical aspects of bacterial toxins as pharmaceuticals | Q38014994 |
| | Aesthetic uses of the botulinum toxin | Q38165363 |
| | Botulinum neurotoxins: genetic, structural and mechanistic insights. | Q38224215 |
| | Immunogenicity assessment of biotherapeutic products: An overview of assays and their utility | Q38542949 |
| | Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin | Q39473584 |
| | Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region | Q39749214 |
| | The Occurrence of Bacillus botulinus, Types A and B, in Accidental Wounds. | Q40699731 |
| | The Families and Genera of the Bacteria: Preliminary Report of the Committee of the Society of American Bacteriologists on Characterization and Classification of Bacterial Types. | Q40722957 |
| | Notes on Bacillus botulinus | Q40723522 |
| | Infant botulism in 1931. Discovery of a misclassified case | Q41043508 |
| | Atropa belladonna (deadly nightshade). | Q42075278 |
| | Neurologic uses of botulinum neurotoxin type A. | Q42086848 |
| | Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles | Q44011948 |
| | A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines | Q44027123 |
| | Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study. | Q45961097 |
| | Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study. | Q46435010 |
| | Anaphylaxis after vaccination due to hypersensitivity to gelatin | Q46967144 |
| | Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation. | Q51038527 |
| | The Use of Sonographically Guided Botulinum Toxin Type A (Dysport) Injections Into the Tensor Fasciae Latae for the Treatment of Lateral Patellofemoral Overload Syndrome. | Q51502806 |
| | Double-blind, randomized non-inferiority trial of a novel botulinum toxin A processed from the strain CBFC26, compared with onabotulinumtoxin A in the treatment of glabellar lines. | Q53076726 |
| | Report of Allergic Reaction After Application of Botulinum Toxin. | Q53471137 |
| | History of the cosmetic use of Botulinum A exotoxin. | Q53565450 |
| | A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. | Q53616488 |
| | Efficacy of botulinum neurotoxin type A for treating recalcitrant plaque psoriasis. | Q53639010 |
| | Prospective Open-Label Study of Botulinum Toxin Type B (Myobloc) at Doses of 2,400 and 3,000 U for the Treatment of Glabellar Wrinkles | Q53862226 |
| | Therapeutic Use of Type F Botulinum Toxin | Q67721881 |
| | Botulinum toxin for the treatment of hyperfunctional lines of the face | Q72894311 |
| | Botulinum A toxin for glabellar wrinkles. Dose and response | Q77621892 |
| | Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines | Q79619697 |
| | Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F | Q79753944 |
| | A randomized double-blind study of the effect of Botox and Dysport/Reloxin on forehead wrinkles and electromyographic activity | Q79913136 |
| | Botulinum toxin type-A for the treatment of inverse psoriasis | Q80947815 |
| | Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis | Q81363551 |
| | Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines | Q82751579 |
| | Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A | Q84114019 |
| | Cosmetic Surgery National Data Bank Statistics | Q89166974 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P433 | issue | suppl_1 | |
| P921 | main subject | botulinum toxin type A | Q4095199 |
| | enzyme | Q8047 |
| | neuromuscular agents | Q50430099 |
| | bacterial protein | Q64923821 |
| P304 | page(s) | S4-S11 | |
| P577 | publication date | 2017-05-01 | |
| P1433 | published in | Aesthetic Surgery Journal | Q4688581 |
| P1476 | title | AbobotulinumtoxinA: A 25-Year History | |
| P478 | volume | 37 | |